ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II trial of weekly nab-paclitaxel with GM-CSF as chemoimmunotherapy for platinum-resistant epithelial ovarian cancer.
Journal of Clinical Oncology
◽
10.1200/jco.2011.29.15_suppl.5020
◽
2011
◽
Vol 29
(15_suppl)
◽
pp. 5020-5020
Author(s):
R. E. Swensen
◽
J. Childs
◽
D. Higgins
◽
T. Gooley
◽
B. A. Goff
◽
...
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Gm Csf
◽
Platinum Resistant
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718128610.793486222
◽
2013
◽
Author(s):
David Kushner
◽
Erin Medlin
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Resistant Refractory
◽
Multicenter Phase
◽
Platinum Resistant
◽
Etirinotecan Pegol
Download Full-text
Faculty Opinions recommendation of Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718128610.793485993
◽
2013
◽
Author(s):
Roberto Angioli
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Resistant Refractory
◽
Multicenter Phase
◽
Platinum Resistant
◽
Etirinotecan Pegol
Download Full-text
A phase II trial of SNS-595 in women with platinum resistant epithelial ovarian cancer
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.5582
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 5582-5582
Author(s):
W. P. McGuire
◽
H. W. Hirte
◽
U. A. Matulonis
◽
R. T. Penson
◽
A. Husain
◽
...
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Platinum Resistant
Download Full-text
Faculty of 1000 evaluation for Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718128610.793486320
◽
2013
◽
Author(s):
Steve Plaxe
◽
Kristy Ward
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Resistant Refractory
◽
Multicenter Phase
◽
Platinum Resistant
◽
Etirinotecan Pegol
Download Full-text
Panitumumab and pegylated liposomal doxorubicin to platinum-resistant epithelial ovarian cancer with KRAS wild-type: An ongoing, nonrandomized, multicenter, phase II trial.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.tps254
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. TPS254-TPS254
◽
Cited By ~ 1
Author(s):
K. D. Steffensen
◽
M. Waldstr∅m
◽
B. Lund
◽
K. Bergfeldt
◽
N. Keldsen
◽
...
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Trial
◽
Pegylated Liposomal Doxorubicin
◽
Wild Type
◽
Multicenter Phase
◽
Platinum Resistant
Download Full-text
Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours
European Journal of Cancer
◽
10.1016/j.ejca.2010.02.047
◽
2010
◽
Vol 46
(9)
◽
pp. 1573-1579
◽
Cited By ~ 87
Author(s):
Helen J. Mackay
◽
Hal Hirte
◽
Terrence Colgan
◽
Al Covens
◽
Katrina MacAlpine
◽
...
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Histone Deacetylase
◽
Phase Ii
◽
Histone Deacetylase Inhibitor
◽
Phase Ii Trial
◽
Platinum Resistant
◽
Deacetylase Inhibitor
◽
Ovarian Tumours
Download Full-text
Temsirolimus in women with platinum-resistant ovarian cancer or advanced/recurrent endometrial cancer: a multicenter phase II trial of the AGO Study Group (AGO-GYN 8)
Geburtshilfe und Frauenheilkunde
◽
10.1055/s-0034-1388557
◽
2014
◽
Vol 74
(S 01)
◽
Author(s):
F Hilpert
◽
C Kurzeder
◽
B Schmalfeldt
◽
P Neuser
◽
N de Gregorio
◽
...
Keyword(s):
Ovarian Cancer
◽
Endometrial Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Study Group
◽
Multicenter Phase
◽
Platinum Resistant
◽
Recurrent Endometrial Cancer
Download Full-text
Faculty Opinions recommendation of PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718144304.793486590
◽
2013
◽
Author(s):
Roberto Angioli
Keyword(s):
Ovarian Cancer
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Trial
◽
Pegylated Liposomal Doxorubicin
◽
Platinum Resistant
◽
Randomized Phase Ii
Download Full-text
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-004-0818-x
◽
2004
◽
Vol 54
(4)
◽
pp. 283-289
◽
Cited By ~ 5
Author(s):
Robert J. Morgan
◽
Timothy W. Synold
◽
David Gandara
◽
Franco Muggia
◽
Sidney Scudder
◽
...
Keyword(s):
Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Recurrent Ovarian Cancer
◽
Platinum Resistant
Download Full-text
A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer
British Journal of Cancer
◽
10.1038/bjc.1992.126
◽
1992
◽
Vol 65
(4)
◽
pp. 621-623
◽
Cited By ~ 20
Author(s):
MJ Lind
◽
BMJ Cantwell
◽
MJ Millward
◽
A Robinson
◽
M Proctor
◽
...
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close